Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04596735 · ClinicalTrials.gov registry record
Extubation Criteria in Patients Greater Than 59 Years of Age
A clinical trial of Extubation and Respiratory Complications, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 4,000
- Enrollment target
- 1
- Study location
NCT04596735: Completed study of Extubation and Respiratory Complications, sponsored by Wake Forest University Health Sciences.
NCT04596735 is a study of Extubation and Respiratory Complications that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 4,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04596735, a study of Extubation and Respiratory Complications, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 4,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospectively evaluate the predictive value of individual pre-specified clinical extubation criteria for extubation success
Primary Outcome
Quality of extubation will be assessed using a standard rubric for all extubation.
Conditions Studied
Study Locations (1)
North Carolina
- Wake Forest Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2020-10-16 |
| Est. Completion | 2025-08-21 |
What the finished NCT04596735 record still lists
NCT04596735 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 2 conditions, with Extubation appearing as the primary indexed condition, and to 0 interventions.
NCT04596735 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT04596735 about?
NCT04596735 is a clinical study titled "Extubation Criteria in Patients Greater Than 59 Years of Age". Prospectively evaluate the predictive value of individual pre-specified clinical extubation criteria for extubation success
What is the current status of trial NCT04596735?
This trial is currently completed. The enrollment target is 4,000 participants. The study started on 2020-10-16. Estimated completion is 2025-08-21.
What conditions does trial NCT04596735 study?
This clinical trial studies the following conditions: Extubation, Respiratory Complications.
Who is sponsoring clinical trial NCT04596735?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04596735 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Extubation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI